Albendazole is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Edenbridge Pharmaceuticals Llc.. The primary component is Albendazole.
Product ID | 42799-110_6c48fd89-cb40-477c-8a78-15cbe0df6faa |
NDC | 42799-110 |
Product Type | Human Prescription Drug |
Proprietary Name | Albendazole |
Generic Name | Albendazole |
Dosage Form | Tablet |
Route of Administration | ORAL |
Marketing Start Date | 2019-05-17 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA211117 |
Labeler Name | Edenbridge Pharmaceuticals LLC. |
Substance Name | ALBENDAZOLE |
Active Ingredient Strength | 2 1/1 |
Pharm Classes | Antihelminthic [EPC],Cytochrome P450 1A Inducers [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-05-17 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | ANDA |
Application Number | ANDA211117 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-05-17 |
Ingredient | Strength |
---|---|
ALBENDAZOLE | 200 mg/1 |
SPL SET ID: | 6c48fd89-cb40-477c-8a78-15cbe0df6faa |
Manufacturer | |
UNII |
NDC | Brand Name | Generic Name |
---|---|---|
0115-1701 | Albendazole | albendazole |
0591-2712 | Albendazole | Albendazole |
16714-907 | Albendazole | Albendazole |
31722-935 | Albendazole | Albendazole |
42291-093 | Albendazole | Albendazole |
42799-110 | Albendazole | Albendazole |
43598-452 | Albendazole | Albendazole |
51407-258 | Albendazole | Albendazole |
54505-055 | Albendazole | Albendazole |
62980-513 | Albendazole | Albendazole |
63629-1221 | Albendazole | Albendazole |
63629-9278 | Albendazole | Albendazole |
69097-237 | ALBENDAZOLE | albendazole |
69539-151 | Albendazole | Albendazole |
70710-1021 | Albendazole | Albendazole |
70771-1103 | Albendazole | Albendazole |
78482-110 | Albendazole | Albendazole |
52054-550 | ALBENZA | albendazole |
55695-021 | ALBENZA | albendazole |
64896-693 | ALBENZA | albendazole |
65084-462 | ALBENZA | albendazole |